|
Video: What is a Stock Split?
|
|
bluebird bio is a biotechnology company focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector gene addition platform. Co. has two gene therapies: ZYNTEGLO® (betibeglogene autotemcel, also known as beti-cel) and SKYSONA® (elivaldogene autotemcel, also known as eli-cel). ZYNTEGLO is for the treatment of adult and pediatric patients with B-thalassemia who require regular red blood cell transfusions. SKYSONA is for slowing the progression of neurologic dysfunction in boys four to 17 years of age with early active cerebral adrenoleukodystrophy. According to our BLUE split history records, bluebird bio has had 1 split. | |
|
bluebird bio (BLUE) has 1 split in our BLUE split history database. The split for BLUE took place on November 05, 2021. This was a 1544 for 1000 split, meaning for each 1000 shares of BLUE owned pre-split, the shareholder now owned 1544 shares. For example, a 1000 share position pre-split, became a 1544 share position following the split.
When a company such as bluebird bio splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the BLUE split history from start to finish, an original position size of 1000 shares would have turned into 1544 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into bluebird bio shares, starting with a $10,000 purchase of BLUE, presented on a split-history-adjusted basis factoring in the complete BLUE split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/24/2014 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$12.92 |
|
End price/share: |
$0.95 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-92.65% |
|
Average Annual Total Return: |
-22.97% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$735.00 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
11/05/2021 | 1544 for 1000 |
|
|